MSIAN GENOMICS RES CENTRE BHD
KLSE (MYR): MGRC (0155)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.49
Today's Change
-0.01 (2.00%)
Day's Change
0.48 - 0.50
Trading Volume
288,400
Financial
Market Cap
64 Million
NOSH
130 Million
Latest Quarter
31-Mar-2023 [#3]
Announcement Date
23-May-2023
Next Quarter
30-Jun-2023
Est. Ann. Date
30-Aug-2023
Est. Ann. Due Date
29-Aug-2023
QoQ | YoY
-132.12% | -245.72%
Revenue | NP to SH
12,468.000 | 748.000
RPS | P/RPS
9.58 Cent | 5.12
EPS | P/E | EY
0.57 Cent | 85.30 | 1.17%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.29 | 1.69
QoQ | YoY
-86.58% | -32.49%
NP Margin | ROE
2.66% | 1.98%
F.Y. | Ann. Date
31-Mar-2023 | 23-May-2023
Latest Audited Result
30-Jun-2022
Announcement Date
25-Oct-2022
Next Audited Result
30-Jun-2023
Est. Ann. Date
25-Oct-2023
Est. Ann. Due Date
27-Dec-2023
Revenue | NP to SH
28,360.000 | 7,211.000
RPS | P/RPS
21.78 Cent | 2.25
EPS | P/E | EY
5.54 Cent | 8.85 | 11.30%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.28 | 1.73
YoY
267.97%
NP Margin | ROE
25.43% | 19.54%
F.Y. | Ann. Date
30-Jun-2022 | 30-Aug-2022
Revenue | NP to SH
8,180.000 | -4,286.666
RPS | P/RPS
6.28 Cent | 7.80
EPS | P/E | EY
-3.39 Cent | -14.88 | -6.72%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-507.18% | -200.03%
NP Margin | ROE
-59.72% | -11.35%
F.Y. | Ann. Date
31-Mar-2023 | 23-May-2023
Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.
Date
Financial Result
Financial Ratio
Per Share Item
Performance
Valuation (End of Quarter)
Valuation (Ann. Date)
| Date | Financial Result | Financial Ratio | Per Share Item | Performance | Valuation (End of Quarter) | Valuation (Ann. Date) | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F.Y. | Ann. Date | Quarter | # | Revenue | PBT | NP | NP to SH | Div | Net Worth | Div Payout % | NP Margin | ROE | NOSH | RPS | Adj. RPS | EPS | Adj. EPS | DPS | Adj. DPS | NAPS | Adj. NAPS | QoQ | YoY | EOQ Date | EOQ Price | EOQ P/RPS | EOQ P/EPS | EOQ P/NAPS | EOQ EY | EOQ DY | ANN Date | ANN Price | ANN P/RPS | ANN P/EPS | ANN P/NAPS | ANN EY | ANN DY |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Discussions
3 people like this. Showing 50 of 1,464 comments
Kenanga Research starts coverage on MGRC, target price RM1.07
https://www.theedgemarkets.com/article/kenanga-research-starts-coverage-mgrc-target-price-rm107
2022-10-31 11:09
slow slow panjat , minggu lepas hijau , minggu ni hijau , minggu depan hijau , tiap tiap minggu hijau !
2022-11-07 13:43
This counter can out of sudden dropped 0.30 in a day ,happened before and Director said not sure what causes UMA. scary
2022-12-15 16:44
Azri actually just one of director , Mgrc helm by Sasha who is ceo of mgrc
2022-12-19 19:31
No need to be bad mood, you may continue to promote. we all can have a free speech and opinion in i3.
2023-01-05 14:30
Hopefully with the exit of Bintai, this counter can move up, and seems like someone is collecting at 0.74
2023-02-22 12:20
A lot of investors don't trust Azri aka the management because of his age. I am also from the younger generation and believe that the old investors should stop adopting the jaded and traditional mentality that youngsters cannot lead a company in the right direction. A short-term stagflation is upon us so this is a great opportunity for the company to seek the next trend in the healthcare/genomics space
1 month ago
PacBio (PACB) Tops on Q1 Earnings, Raises FY23 Revenue View
The healthcare sector is still doing well, i have no worries.
1 month ago
sell-side traders how many lots do you need to dispose for your client?
3 weeks ago
keep posting on Linkedin asking people to buy. you think we don't know? no one is gonna be foolish to buy
3 weeks ago
Go follow Azerai Ahmad on Linkedin and you guys will know what I am talking about. Sell-side traders not enough power to dump on retail investors so the father has to promote the stock
3 weeks ago
Let put our fingers crossed
As highlighted by public bank security
On 28/4 first resistance at 65 Cts followed by 72.5
3 weeks ago
QR is out. Probably need to wait a few more quarters for its new business to be profitable
1 week ago
Post a Comment
Featured Posts
[07 JUN] Uncovering the future stars of the Asian market
Looking for REITs with high returns? Check this out!
[14 MAR-30 JUN] Invite friends to join MQ Trader for extra 1,000 MQ Coins!
Apps
Top Articles
1
Good Articles to Share
India train crash survivor recounts: 'We thought we were dead'
2
Good Articles to Share
3
Good Articles to Share
4
Good Articles to Share
North Korea slams UN meeting on satellite launch, 'robbery' US demand
5
Good Articles to Share
6
7
Good Articles to Share
8
Good Articles to Share
UK's Sunak says he wants to build on Biden ties in Washington trip
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
winlast
MGRC reach bottom low aleady, will technical rebound solidly and strongly
2022-08-19 13:45